Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.4398-4400
2016
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Potential Use of Fosfomycin-Tromethamine for Treatment of Recurrent Campylobacter Species Enteritis
- Ist Teil von
- Antimicrobial agents and chemotherapy, 2016-07, Vol.60 (7), p.4398-4400
- Ort / Verlag
- United States: American Society for Microbiology
- Erscheinungsjahr
- 2016
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 0066-4804eISSN: 1098-6596DOI: 10.1128/aac.00447-16Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4914669
- Format
- –
- Schlagworte
- Agammaglobulinemia - drug therapy, Aged, 80 and over, Anti-Bacterial Agents, Anti-Bacterial Agents - therapeutic use, Campylobacter, Campylobacter - drug effects, Campylobacter - pathogenicity, Campylobacter coli, Clinical Therapeutics, Enteritis, Enteritis - drug therapy, Female, Fosfomycin, Fosfomycin - therapeutic use, Humans, Microbial Sensitivity Tests, Middle Aged, Tromethamine, Tromethamine - therapeutic use